Eli Lilly and Company, headquartered in Indianapolis, Indiana, is a global leader in pharmaceutical innovation and healthcare solutions. With a rich history dating back to 1876, the company is committed to discovering, developing, and delivering life-changing medicines that address critical health challenges. Lilly focuses on advancing therapies in areas such as oncology, diabetes, immunology, neuroscience, and more.
Lilly is at the forefront of developing groundbreaking cancer therapies, including Imlunestrant, an oral medication designed to treat estrogen receptor-positive (ER+) breast cancer. To help communicate the complexity and effectiveness of Imlunestrant, Lilly collaborated with Ghost Medical, a leading medical marketing and training studio. Ghost Medical created a compelling motion graphic for Lilly that illustrates the mechanism of action of Imlunestrant. The animation highlights the differences between normal estrogen binding and Imlunestrant binding within the cellular structure, including the nucleus, cell wall, and estrogen receptors. It vividly demonstrates how Imlunestrant disrupts estrogen binding and promotes receptor degradation, showcasing its therapeutic impact on ER+ breast cancer.
Ghost Medical is an award-winning leader in medical visualization, specializing in custom medical animation, medical marketing services, and surgical training solutions. We provide a comprehensive range of digital services designed to elevate medical marketing, enhance patient communication, and streamline staff training. With a team of highly skilled professionals and deep expertise in biomedical processes, we ensure precise and impactful representations of your device, product, or procedure through 3D animations, medical illustration, and other dynamic media formats. Contact Ghost Medical today to discover how we can help you train surgeons, boost medical device sales, or effectively communicate your pharmaceutical innovations.
Start a Project
© 2024 Ghost Productions, Inc.
